The Emerging Problems of Carbapenem-Resistant Gram- Negative Bacillary Pneumonia
Author:
Ionescu Mihaela Ileana
Reference54 articles.
1. Sutherasan Y, Peñuelas O, Muriel A, Vargas M, Frutos-Vivar F, Brunetti I, et al. Management and outcome of mechanically ventilated patients after cardiac arrest. Critical Care. 2015;19:215. DOI: 10.1186/s13054-015-0922-9
2. Suwantarat N, Carroll KC. Epidemiology and molecular characterization of multidrug-resistant gram-negative bacteria in Southeast Asia. Antimicrobila Resistance and Infection Control. 2016;5:15. DOI: 10.1186/s13756-016-0115-6
3. Le NK, Hf W, Vu PD, Khu DTK, Le HT, Hoang BTN, et al. High prevalence of hospital-acquired infections caused by gram-negative carbapenem resistant strains in Vietnamese pediatric ICUs: A multi-centre point prevalence survey. Medicine (Baltimore). 2016;95:e4099. DOI: 10.1097/MD.0000000000004099
4. Tamma PD, Han JH, Rock C, Harris AD, Lautenbach E, Hsu AJ, et al. Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum β-lactamase bacteremia. Clinical Infectious Diseases. 2015;60:1319-1325. DOI: 10.1093/cid/civ003
5. Shapira S, Pleban S, Kazanov D, Tirosh P, Arber N. Terpinen-4-ol: A novel and promising therapeutic agent for human gastrointestinal cancers. PLoS One. 2016;11:e0156540. DOI: 10.1371/journal.pone.0156540